ISSN: 0360-3016

International Journal of Radiation Oncology Biology Physics Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Radiation Oncology Biology Physics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 268. It is an CC BY-NC-ND Journal with a Double blind Peer Review review system The scope of the journal is focused on Cancer, Radiation Oncology, Oncology, Medical Physics. It has an SJR impact factor of 2,09 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,09.

International Journal of Radiation Oncology Biology Physics focuses its scope in these topics and keywords: cancer, radiation, therapy, prostate, radiotherapy, patients, cell, lung, treated, treatment, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1) Radiation (Q1) Radiology, Nuclear Medicine and Imaging (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,09

SJR Impact factor

268

H Index

512

Total Docs (Last Year)

1804

Total Docs (3 years)

13527

Total Refs

6847

Total Cites (3 years)

1127

Citable Docs (3 years)

3.76

Cites/Doc (2 years)

26.42

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

High-speed magnetic resonance imaging for four-dimensional treatment planning of conformal radiotherapy of moving body tumors

Conformal radiotherapy for paranasal sinus and nasal cavity tumors: three-dimensional treatment planning and preliminary results in 40 patients

76 Neuropsychological function in adults after high dose fractionated radiation therapy of skull base sarcomas

408 Radiotherapy for pediatric brain tumors standards of care, current clinical trials, and new directions

The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma

161 Prolonged G2 delay in murine lymphoma cells susceptible to radiation-induced apoptosis correlates with cyclin B1 expression

60 Identification and characterization of the gene responsible for the radiosensitive phenotype of scid mice

Toward optimal external-beam fractionation for prostate cancer

Three-dimensional small-volume irradiation for residual or recurrent nasopharyngeal carcinoma

Blood hemoglobin level may affect radiosensitivity - preliminary results on acutely reacting normal tissues

Concomitant boost radiation therapy for inoperable non-small-cell lung cancer: preliminary report of a prospective randomized study

10 Prognostic factors associated with radiosurgery for malignant glioma: Results of a multi institutional Gamma Knife study

SHOW MORE ARTICLES

In response to Dr. Yaes

In response to Drs. Mehrkens, Stummer, and Kreth

In response to Drs. Rousseau and Gibon

In response to Drs. Vaarkamp and Zhu

In response to Drs. Wilson and Lim

Optimizing for the Gamma Knife

Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

26 Quantification of regional lung injury with serial spect lung perfusion imaging

64 evaluation of a gene therapy system using a replication competent, non-neurovirulent HSV-1 viral vector used tn combination with radiotherapy

Intensity-modulated radiotherapy: rethinking basic treatment planning paradigms

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

52 A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous bone metastases-RTOG 88-22